ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 156

Menopause and the Prevalence of Gout and Hyperuricemia: An Age-Matched Case Control Study

Eswar Krishnan1 and Mihoko Bennett2, 1Medicine, Standford University, Palo Alto, CA, 2Pediatrics, Stanford University, Palo Alto, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: gout, menopause, risk assessment and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Among women, the prevalence of gouty arthritis (gout) and hyperuricemia (serum urate>6.0 mg/dL) increases steeply after the age 60. This increase has been attributed to menopause, and its attendant declines in circulating concentrations of reproductive hormones.  However it is not clear whether the ‘effect’ of menopause is merely a reflection of increasing age as these two factors are tightly correlated.

Methods: We performed multiple unmatched and age matched  case-control analyses using data on women aged 20-60 years from the NHANES1999-2010 cycles. For the latter, each case of gout, defined as self-reported physician diagnosis, 3 age-matched controls were chosen at random. Menopause was defined as absence of menstrual bleeding in the preceding 12 months, excluding those caused by pregnancy, medications, hormones, medical conditions or surgical procedures. Unmatched and matched multivariable analyses were performed by Survey weighted logistic regressions that adjusted for age, body mass index, ethnicity, hypertension and serum creatinine. Models were repeated with hyperuricemia as the outcome variable.

Results: A) Gout: In unmatched analyses,  the bivariate and multivariable  odds ratio for menopause were 3.0(1.4,6.5) and 1.3(0.6,2.7) respectively. In the age-matched analyses, bivariate odds ratio was 0.9 (0.4,1.8) and multivariate odds ratio was not significant. B) Hyperuricemia: In unmatched analyses the odds ratio for menopause in bivariate and multivariable models were 2.3 (2.0-2.8) and 1.25(1.01-1.54) respectively. In age-matched logistic regression models,  the bivariate and multivariable odds ratios were 1.3(1.1,1.4) and 0.98(0.86-1.11) respectively

Conclusion: After offsetting the effect of age by matching, menopausal status was not associated with increased prevalence of gout or hyperuricemia.


Disclosure:

E. Krishnan,

savient,

1,

URL, takeda, metbolex,ARDEA,

2,

METABOLEX TAKEDA,

5;

M. Bennett,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/menopause-and-the-prevalence-of-gout-and-hyperuricemia-an-age-matched-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology